{"type":"answer","id":322042,"parentType":"question","parentId":19424,"uid":44993,"contents":"@懦夫斯基<br>\n<br>\n讨论疫苗临床实验的技术问题会被列观察？<br>\n<br>\n补充点东西<br>\n疫苗三期临床就是需要社会中有足够的患者<br>\n<br>\n路透社：<a href=\"https://www.reuters.com/article/us-health-coronavirus-china-vaccine/chinas-cansino-in-talks-for-covid-19-vaccine-phase-iii-trial-overseas-idUSKCN24C0HS\" rel=\"nofollow noreferrer noopener\" target=\"_blank\">https://www.reuters.com/article/us-health-coronavirus-china-vaccine/chinas-cansino-in-talks-for-covid-19-vaccine-phase-iii-trial-overseas-idUSKCN24C0HS</a><br>\n<br>\n其中提到：<br>\nChina’s success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countries have agreed to work with it.<br>\n<br>\n路透社：<a href=\"https://cn.reuters.com/article/iii-idCNL4S2E102J\" rel=\"nofollow noreferrer noopener\" target=\"_blank\">https://cn.reuters.com/article/iii-idCNL4S2E102J</a><br>\n<br>\n其中提到：<br>\n这些试验涉及到数千名参与者，通常在病毒广泛传播的国家进行，这样可以在真实环境中观察疫苗的效果。<br>\n<br>\n但中国上个月报告的日均本土新增病例少于10例，研究人员正放眼海外。","date":"2020-08-13","agreeCount":0,"discussionCount":3}